Cargando…

Antibody Response to HML‐2 May Be Protective in Amyotrophic Lateral Sclerosis

OBJECTIVES: Reactivation of HERV‐K(HML‐2) has been found in subsets of individuals with amyotrophic lateral sclerosis (ALS). This study examines the antibody response against HML‐2 in ALS and analyzes its clinical relevance. METHODS: Antibodies to HML‐2 envelope (env) were analyzed using a peptide a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia‐Montojo, Marta, Simula, Elena Rita, Fathi, Saeed, McMahan, Cynthia, Ghosal, Anubrata, Berry, James D., Cudkowicz, Merit, Elkahloun, Abdel, Johnson, Kory, Norato, Gina, Jensen, Peter, James, Tony, Sechi, Leonardo A., Nath, Avindra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9805205/ https://www.ncbi.nlm.nih.gov/pubmed/36053951 http://dx.doi.org/10.1002/ana.26466

Ejemplares similares

SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression
por: Doucet-O’Hare, Tara T., et al.
Publicado: (2021)

Technical considerations in detection of HERV-K in amyotrophic lateral sclerosis: selection of controls and the perils of qPCR
por: Garcia-Montojo, Marta, et al.
Publicado: (2019)

Transcriptional profiling of HERV-K(HML-2) in amyotrophic lateral sclerosis and potential implications for expression of HML-2 proteins
por: Mayer, Jens, et al.
Publicado: (2018)

Differential expression of an endogenous retroviral element [HERV-K(HML-6)] is associated with reduced survival in glioblastoma patients
por: Shah, Ashish H., et al.
Publicado: (2022)

Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis
por: Li, Wenxue, et al.
Publicado: (2022)

Human Endogenous Retrovirus K (HML-2) in Health and Disease
por: Xue, Bei, et al.
Publicado: (2020)

Military Service and Amyotrophic Lateral Sclerosis in a Population-based Cohort
por: Weisskopf, Marc G., et al.
Publicado: (2015)

HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19
por: Garcia-Montojo, Marta, et al.
Publicado: (2021)

Serum Ferritin and Metal Levels as Risk Factors for Amyotrophic Lateral Sclerosis
por: Qureshi, Muddasir, et al.
Publicado: (2008)

A Mixed Methods System for the Assessment of Post Exertional Malaise in Encephalomyelitis/Chronic Fatigue Syndrome
por: Stussman, Barbara, et al.
Publicado: (2023)

A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex
por: Jones, Ashley R., et al.
Publicado: (2021)

Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post‐mortem motor cortex and cerebrospinal fluid
por: Petrozziello, Tiziana, et al.
Publicado: (2021)

Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS
por: Goyal, Namita A., et al.
Publicado: (2020)

Author Correction: A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex
por: Jones, Ashley R., et al.
Publicado: (2022)

Identification of the distribution of human endogenous retroviruses K (HML-2) by PCR-based target enrichment sequencing
por: Xue, Bei, et al.
Publicado: (2020)

Enhanced Bulbar Function in Amyotrophic Lateral Sclerosis: The Nuedexta Treatment Trial
por: Smith, Richard, et al.
Publicado: (2017)

Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design
por: Berry, James, et al.
Publicado: (2021)

Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis
por: Thonhoff, Jason R., et al.
Publicado: (2022)

Ancient Adversary – HERV-K (HML-2) in Cancer
por: Dervan, Eoin, et al.
Publicado: (2021)

Survival analyses from the CENTAUR trial in amyotrophic lateral sclerosis: Evaluating the impact of treatment crossover on outcomes
por: Paganoni, Sabrina, et al.
Publicado: (2022)

IL6 receptor(358)Ala variant and trans-signaling are disease modifiers in amyotrophic lateral sclerosis
por: Wosiski-Kuhn, Marlena, et al.
Publicado: (2019)

Initial Identification of a Blood-Based Chromosome Conformation Signature for Aiding in the Diagnosis of Amyotrophic Lateral Sclerosis
por: Salter, Matthew, et al.
Publicado: (2018)

Design and Initial Results of a Multi-Phase Randomized Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis
por: Berry, James D., et al.
Publicado: (2013)

Cromolyn sodium delays disease onset and is neuroprotective in the SOD1(G93A) Mouse Model of amyotrophic lateral sclerosis
por: Granucci, Eric J., et al.
Publicado: (2019)

Phase 2B randomized controlled trial of NP001 in amyotrophic lateral sclerosis: Pre‐specified and post hoc analyses
por: Miller, Robert G., et al.
Publicado: (2022)

Profound Muscle Weakness and Pain after One Dose of Actonel
por: Badayan, Irina, et al.
Publicado: (2009)

Identification of a novel HERV-K(HML10): comprehensive characterization and comparative analysis in non-human primates provide insights about HML10 proviruses structure and diffusion
por: Grandi, Nicole, et al.
Publicado: (2017)

Ibudilast (MN-166) in amyotrophic lateral sclerosis- an open label, safety and pharmacodynamic trial
por: Babu, Suma, et al.
Publicado: (2021)

Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic
por: Steiner, Joseph P., et al.
Publicado: (2022)

Glial activation colocalizes with structural abnormalities in amyotrophic lateral sclerosis
por: Alshikho, Mohamad J., et al.
Publicado: (2016)

Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis
por: Nicholson, Katharine, et al.
Publicado: (2018)

Derivation of Neural Stem Cells from Human Adult Peripheral CD34+ Cells for an Autologous Model of Neuroinflammation
por: Wang, Tongguang, et al.
Publicado: (2013)

Apparent Ploidy Effects on Silencing Are Post-Transcriptional at HML and Telomeres in Saccharomyces cerevisiae
por: McLaughlan, Jenny M., et al.
Publicado: (2012)

Identification of late assembly domains of the human endogenous retrovirus-K(HML-2)
por: Chudak, Claudia, et al.
Publicado: (2013)

Identification of late assembly domains of the human endogenous retrovirus-K(HML-2)
por: Chudak, Claudia, et al.
Publicado: (2013)

Comprehensive identification and characterization of the HERV-K (HML-9) group in the human genome
por: Jia, Lei, et al.
Publicado: (2022)

Identification of differentially expressed HERV-K(HML-2) loci in colorectal cancer
por: Kang, Qian, et al.
Publicado: (2023)

Exploring HERV-K (HML-2) Influence in Cancer and Prospects for Therapeutic Interventions
por: Costa, Bárbara, et al.
Publicado: (2023)

Apolipoprotein B-100-mediated motor neuron degeneration in sporadic amyotrophic lateral sclerosis
por: Wong, Jamie K, et al.
Publicado: (2022)

Improving clinical trial outcomes in amyotrophic lateral sclerosis
por: Kiernan, Matthew C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fh3b07cvi25lk0d6a6igh8j9f3